Related Experiment Video
Updated: Jul 14, 2026
04:44
Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
[Interleukin 13 and interleukin 13 receptor involvement in systemic sclerosis].
B Granel1, C Chevillard, A Dessein
1Inserm, U399, laboratoire d'immunologie et de génétique des maladies parasitaires, faculté de médecine de La Timone, 27, boulevard Jean-Moulin, 13385 Marseille cedex 05, France. brigitte.granel@medecine.univ-mrs.fr
La Revue De Medecine Interne
|June 5, 2007
Summary
Genetic variations in interleukin 13 (IL-13) and its receptor (IL-13R) are linked to systemic sclerosis. This finding suggests IL-13 pathway
Area of Science:
- Immunology
- Genetics
- Rheumatology
Context:
- Interleukin 13 (IL-13) is a key cytokine in inflammation and fibrosis.
- Systemic sclerosis (scleroderma) is an autoimmune disease marked by fibrosis.
- The role of IL-13 in systemic sclerosis pathogenesis is under investigation.
Purpose:
- To investigate the association between polymorphisms in IL-13 and IL-13 receptor genes and systemic sclerosis.
- To explore the potential genetic contribution of the IL-13 pathway to disease susceptibility.
Summary:
- Significant associations were found between specific IL-13 and IL-13RA2 gene polymorphisms and systemic sclerosis, particularly the diffuse cutaneous form.
- These findings suggest a genetic link between the IL-13 pathway and systemic sclerosis development.
Impact:
- The study identifies potential genetic markers for systemic sclerosis susceptibility.
- It highlights the IL-13/IL-13R pathway as a potential therapeutic target for systemic sclerosis.
- Further validation in larger populations and functional studies are warranted.
Related Concept Videos
01:24T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
01:20The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...